Literature DB >> 33660357

Review of oral minoxidil as treatment of hair disorders: in search of the perfect dose.

A Villani1, G Fabbrocini1, J Ocampo-Candiani2, A Ruggiero1, S S Ocampo-Garza1,2.   

Abstract

Topical minoxidil has been used for many years as treatment for different hair disorders. Even though it is an effective therapy, many patients show poor compliance due to the cosmesis, cost and side-effects. During the last few years, low-dose oral minoxidil has proven to be an alternative for patients with alopecia. We performed a literature search including all the articles that used oral minoxidil as a primary treatment in various hair diseases in order to evaluate the efficacy and safety of low-dose oral minoxidil as an alternative to topical minoxidil. Androgenetic alopecia was the most common studied condition, but others included telogen effluvium, tractional alopecia, postchemotherapy-induced alopecia, monilethrix, loose anagen hair syndrome, alopecia areata and scarring alopecias (frontal fibrosing alopecia and lichen planopilaris). Larger randomized comparative studies including standardized objective measurements should be done in order to clarify the best treatment protocol, including dosage and treatment duration. Oral minoxidil has proven to be a successful and well-tolerated alternative for patients with hair loss, including those with poor adherence to other therapies. Different dosing regimens have been utilized in scarring and non-scarring alopecia, varying from 0.25 to 5 mg daily. Higher doses have not been studied in men or women. Available literature suggests women require lower doses, from 0.25 to 2.5 mg daily, while men require higher doses for maximal efficacy, from 1.25 to 5 mg a day.
© 2021 European Academy of Dermatology and Venereology.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33660357     DOI: 10.1111/jdv.17216

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN: 0926-9959            Impact factor:   6.166


  5 in total

Review 1.  Pharmacological Management of Pattern Hair Loss.

Authors:  Sandeep Suresh Sattur; Indu Sandeep Sattur
Journal:  Indian J Plast Surg       Date:  2021-12-13

Review 2.  Frontiers in Lichen Planopilaris and Frontal Fibrosing Alopecia Research: Pathobiology Progress and Translational Horizons.

Authors:  Maryanne Makredes Senna; Erik Peterson; Ivan Jozic; Jérémy Chéret; Ralf Paus
Journal:  JID Innov       Date:  2022-03-01

3.  There Is a Positive Dose-Dependent Association between Low-Dose Oral Minoxidil and Its Efficacy for Androgenetic Alopecia: Findings from a Systematic Review with Meta-Regression Analyses.

Authors:  Aditya K Gupta; Deanna C Hall; Mesbah Talukder; Mary A Bamimore
Journal:  Skin Appendage Disord       Date:  2022-06-30

4.  Pericardial, pleural effusion and anasarca: A rare complication of low-dose oral minoxidil for hair loss.

Authors:  Ncoza C Dlova; Tarryn Jacobs; Satish Singh
Journal:  JAAD Case Rep       Date:  2022-08-11

5.  Coupling of Fused Deposition Modeling and Inkjet Printing to Produce Drug Loaded 3D Printed Tablets.

Authors:  Laura Andrade Junqueira; Atabak Ghanizadeh Tabriz; Francisco José Raposo; Luana Rocha Carobini; Urias Pardócimo Vaz; Marcos Antônio Fernandes Brandão; Dennis Douroumis; Nádia Rezende Barbosa Raposo
Journal:  Pharmaceutics       Date:  2022-01-10       Impact factor: 6.321

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.